Unregulated levels of myc protein, the gene product from the c- myc proto-oncogene, are causal in the progressive development of malignant transformation in a variety of animal and human tumors. The focus of this project is to study the regulation of two processes which are important for determining the amount of myc protein in cells: c-myc transcription and c-myc mRNA stability. The proposed study will elucidate normal regulatory events and will also reveal how disruption of particular mechanisms can result in malignant transformation. The overall approach is to dissect biochemically and genetically the function of individual proteins with the ultimate goal of reproducing regulated c-myc transcription and mRNA degradation from purified components in vitro. We also wish to elucidate the molecular nature of the nucleic acid-protein and protein-protein interactions involved. Transcriptional regulation involves multiple proteins, most currently unknown, which somhow interact to form stable initiation complexes. Two c-myc transcription factors, previously identified in this lab, will be purified so that cDNAs encoding them can be cloned and expressed. Availability of cDNA clones and purified protein will allow the transcriptional activity of these factors to be studied in vitro and the nature of their interactions with DNA and other proteins to be determined. We will also study their regulated expression using both cDNAs and antibodies. In addition, all proteins binding 5' of the c-myc transcription start sites and in the transcription pausing region will be identified and subsequently analyzed for differential activity when c-myc transcription is modulated. Additional factors will be studied, as described above. Very little is understood regarding mRNA stability. Recently, this lab has developed a simple in vitro system which reproduces the regulated degradation of c-myc mRNA observed in vivo. This puts us in a strong position to identify, purify and characterize factors which are responsible for regulated c-myc mRNA degradation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA038571-04
Application #
3176623
Study Section
Molecular Biology Study Section (MBY)
Project Start
1988-09-01
Project End
1993-05-31
Budget Start
1988-09-01
Budget End
1989-05-31
Support Year
4
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
Schools of Medicine
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10027
Numoto, M; Niwa, O; Kaplan, J et al. (1993) Transcriptional repressor ZF5 identifies a new conserved domain in zinc finger proteins. Nucleic Acids Res 21:3767-75
Riggs, K J; Saleque, S; Wong, K K et al. (1993) Yin-yang 1 activates the c-myc promoter. Mol Cell Biol 13:7487-95
Shrivastava, A; Saleque, S; Kalpana, G V et al. (1993) Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc. Science 262:1889-92
Roman, C; Matera, A G; Cooper, C et al. (1992) mTFE3, an X-linked transcriptional activator containing basic helix-loop-helix and zipper domains, utilizes the zipper to stabilize both DNA binding and multimerization. Mol Cell Biol 12:817-27
Cooper, C; Johnson, D; Roman, C et al. (1992) The C/EBP family of transcriptional activators is functionally important for Ig VH promoter activity in vivo and in vitro. J Immunol 149:3225-31
Riggs, K J; Merrell, K T; Wilson, G et al. (1991) Common factor 1 is a transcriptional activator which binds in the c-myc promoter, the skeletal alpha-actin promoter, and the immunoglobulin heavy-chain enhancer. Mol Cell Biol 11:1765-9
Roman, C; Cohn, L; Calame, K (1991) A dominant negative form of transcription activator mTFE3 created by differential splicing. Science 254:94-7
Roman, C; Platero, J S; Shuman, J et al. (1990) Ig/EBP-1: a ubiquitously expressed immunoglobulin enhancer binding protein that is similar to C/EBP and heterodimerizes with C/EBP. Genes Dev 4:1404-15
Peterson, C L; Calame, K (1989) Proteins binding to site C2 (muE3) in the immunoglobulin heavy-chain enhancer exist in multiple oligomeric forms. Mol Cell Biol 9:776-86
Kakkis, E; Mercola, M; Calame, K (1988) Strong transcriptional activation of translocated c-myc genes occurs without a strong nearby enhancer or promoter. Nucleic Acids Res 16:77-96

Showing the most recent 10 out of 17 publications